Cite

HARVARD Citation

    Ochoa, S. et al. (2021). Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti–Interferon-γ Autoantibodies. Clinical infectious diseases. pp. 2206-2208. [Online]. 
  
Back to record